NC
Nathan Clumeck

Elite Scholar

661
Works
21,120
Citations
64
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5109329435
  • i10-Index 193
  • 2-Yr Mean Citedness 0.00
External Links
OpenAlex Profile

Nathan Clumeck

Also known as: Clumeck N, Clumeck N., Clumeck Nathan, Clumeck, N, Clumeck, N.

661

Total Works

21,120

Citations

64

H-Index

193

i10-Index

Citation & Works Trend by Year
48 years active
Top Research Topics
HIV/AIDS Research and Interventions (290) HIV Research and Treatment (278) HIV/AIDS drug development and treatment (267) HIV-related health complications and treatments (89) Infectious Diseases and Tuberculosis (56)
Recent Publications
15 shown
Year Publication Title Citations Action
2025 Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe JHEP Reports 1
2024 Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration Clinical Infectious Diseases 31
2022 Observational cohort study of rilpivirine (RPV) utilization in Europe AIDS Research and Therapy 5
2020 Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons Open Forum Infectious Diseases 2
2020 Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff Journal of Hospital Infection 101
2020 Treatment of Toxoplasmic Encephalitis in Patients with AIDS Annals of Internal Medicine 0
2018 Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic Clinical Infectious Diseases 8
2018 Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases The International Journal of Tuberculosis and Lung Disease 23
2017 Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study Open Forum Infectious Diseases 19
2017 Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial The Lancet HIV 35
2017 Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy Epidemiology and Infection 2
2017 Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015 Open Forum Infectious Diseases 17
2016 Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors Scientific Reports 13
2016 Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study The Lancet Infectious Diseases 64
2016 Opportunistic Infections Elsevier eBooks 3

Data source: OpenAlex API